<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2001 (7) TMI 557 - CEGAT, NEW DELHI</title>
    <link>https://www.taxtmi.com/caselaws?id=97960</link>
    <description>The appeal by M/s. Ranbaxy Laboratories was allowed by the Appellate Tribunal CEGAT, New Delhi. The tribunal found that the invoices contained the necessary details for Modvat credit, and the allegation of excess duty payment was not raised in the show cause notice. The impugned order disallowing Modvat credit was set aside.</description>
    <language>en-us</language>
    <pubDate>Mon, 16 Jul 2001 00:00:00 +0530</pubDate>
    <lastBuildDate>Wed, 18 Jan 2012 16:51:20 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=135017" rel="self" type="application/rss+xml"/>
    <item>
      <title>2001 (7) TMI 557 - CEGAT, NEW DELHI</title>
      <link>https://www.taxtmi.com/caselaws?id=97960</link>
      <description>The appeal by M/s. Ranbaxy Laboratories was allowed by the Appellate Tribunal CEGAT, New Delhi. The tribunal found that the invoices contained the necessary details for Modvat credit, and the allegation of excess duty payment was not raised in the show cause notice. The impugned order disallowing Modvat credit was set aside.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Mon, 16 Jul 2001 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=97960</guid>
    </item>
  </channel>
</rss>